Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
3.49
-0.05
(-1.41%)
USD |
NASDAQ |
Sep 09, 12:07
Shuttle Pharmaceuticals Holdings Price to Book Value : 0.5789 for Sept. 9, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 08, 2026 | 0.5872 |
| September 04, 2026 | 0.5806 |
| September 03, 2026 | 0.5773 |
| September 02, 2026 | 0.579 |
| September 01, 2026 | 0.5989 |
| August 31, 2026 | 0.5574 |
| August 28, 2026 | 0.5872 |
| August 27, 2026 | 0.6437 |
| August 26, 2026 | 0.5955 |
| August 25, 2026 | 0.5707 |
| August 24, 2026 | 0.5839 |
| August 21, 2026 | 0.6237 |
| August 20, 2026 | 0.6155 |
| August 19, 2026 | 0.6237 |
| August 18, 2026 | 0.6503 |
| August 17, 2026 | 0.6801 |
| August 14, 2026 | 0.6752 |
| August 13, 2026 | 0.7598 |
| August 12, 2026 | 0.7017 |
| August 11, 2026 | 0.715 |
| August 10, 2026 | 0.6752 |
| August 07, 2026 | 0.7233 |
| August 06, 2026 | 0.7266 |
| August 05, 2026 | 0.7631 |
| August 04, 2026 | 0.6055 |
| Date | Value |
|---|---|
| August 03, 2026 | 0.559 |
| July 31, 2026 | 0.6304 |
| July 30, 2026 | 0.5126 |
| July 29, 2026 | 0.4612 |
| July 28, 2026 | 0.4628 |
| July 27, 2026 | 0.4844 |
| July 24, 2026 | 0.4794 |
| July 23, 2026 | 0.496 |
| July 22, 2026 | 0.5076 |
| July 21, 2026 | 0.5557 |
| July 20, 2026 | 0.5026 |
| July 17, 2026 | 0.5242 |
| July 16, 2026 | 0.5889 |
| July 15, 2026 | 0.6055 |
| July 14, 2026 | 0.6901 |
| July 13, 2026 | 0.491 |
| July 10, 2026 | 0.4844 |
| July 09, 2026 | 0.5441 |
| July 08, 2026 | 0.5922 |
| July 07, 2026 | 0.5408 |
| July 06, 2026 | 0.5806 |
| July 02, 2026 | 0.5939 |
| July 01, 2026 | 0.564 |
| June 30, 2026 | 0.5391 |
| June 29, 2026 | 0.5391 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.662 |
| Alnylam Pharmaceuticals, Inc. | 25.16 |
| Anika Therapeutics, Inc. | 2.043 |
| Savara, Inc. | 7.699 |
| Vericel Corp. | 5.374 |
Price to Book Value Related Metrics
| Price | 3.49 |
| Earnings Yield | -1.74K% |
| Market Cap | 1.937M |